Michèle M Kislan1, Adam T Bernstein2, Loretta R Fearrington3, Timothy J Ives4,5. 1. Yakima Valley Memorial Hospital, Yakima, WA, 98902, USA. MicheleKislan@yvmh.org. 2. Department of Pharmacy, University of North Carolina Health Care, Chapel Hill, NC, 27514, USA. 3. The North Carolina Translational & Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7064, USA. 4. Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7574, USA. 5. Division of General Medicine and Clinical Epidemiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7110, USA.
Following the publication of this article [1] it was brought to our attention that there was an error in the ‘Total cost’ paragraph of the ‘Results’ section.The paragraph currently reads: “The total cost of OPV, EDV, IA, and prescribed medications in the CPP-R cohort was 1.46% lower, as compared to the PCP-A cohort (p = 0.026) (Data not shown due to proprietary nature of data).”This should instead read: “The total cost of OPV, EDV, IA, and prescribed medications in the CPP-R cohort was 119.6% lower, as compared to the PCP-A cohort (p = 0.026) (Data not shown due to proprietary nature of data).”